Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Caladrius Biosciences Inc (NASDAQ:CLBS)

4.50
Delayed Data
As of Jun 23
 +0.22 / +5.14%
Today’s Change
2.65
Today|||52-Week Range
7.79
+59.01%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash45.4M19.2M20.3M14.7M
 
 
 
 
 
Short Term Investment Cash32.4M-27.0M1.1M-5.6M
 
 
 
 
 
Cash & Short Term Investments46.1M26.3M20.3M14.7M
 
 
 
 
 
 
ReceivablesReceivables1.9M3.1M2.6M2.9M
 
 
 
 
 
 
InventoriesInventories1.3M0.000.000.00
 
 
 
Current AssetsOther Current Assets1.6M4.3M3.5M3.5M
 
 
 
 
 
Current Assets50.8M33.7M26.4M21.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross15.9M21.4M24.6M25.6M
 
 
 
 
 
Depreciation-3.0M-5.4M-7.5M-8.4M
 
 
 
 
 
Intangible Assets25.0M72.8M9.9M9.3M
 
 
 
 
 
Other Assets26.1M76.6M13.8M13.6M
 
 
 
 
 
Total Assets89.8M126.3M57.2M51.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.4M5.7M4.1M4.4M
 
 
 
 
 
Short Term Debt594.2K1.9M5.4M4.0M
 
 
 
 
 
Accrued Expenses1.7M1.5M3.4M1.9M
 
 
 
 
 
Other Current Liabilities3.5M5.8M8.8M7.0M
 
 
 
 
 
Other Liabilities9.8M16.2M21.0M19.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.6M14.7M11.4M2.8M
 
 
 
 
 
Deferred Taxes-4.4M-18.2M-932.7K-1.1M
 
 
 
 
 
Other Liabilities10.0M804.5K562.0K389.9K
 
 
 
 
 
Total Liabilities27.8M68.2M33.9M28.4M
 
 
 
 
 
 
EquityMinority Interest-504.1K-593.3K-124.5K-653.2K
 
 
 
 
 
Preferred Stock100.00100.00100.0019.4M
 
 
 
 
 
Common Equity62.5M58.5M23.7M4.9M
 
 
 
 
 
Total Shareholder Equity62.5M58.5M23.7M24.3M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding2.7M3.7M5.7M8.2M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.